E-LIB Suche - Ergebnisse für: Prytz, H.

1

Incidence, clinical presentation and mortality of liver cir..:

Nilsson, E. ; Anderson, H. ; Sargenti, K...
Alimentary Pharmacology & Therapeutics. 43 (2016) 12 - p. 1330-1339 , 2016

Link: https://doi.org/10.1111/..

2

P0160 : Liver cirrhosis in Southern Sweden 2001-2011: A pop..:

Nilsson, E. ; Sargenti, K. ; Anderson, H..
Journal of Hepatology. 62 (2015) - p. S362-S363 , 2015

Link: https://doi.org/10.1016/..

3

High dose ursodeoxycholic acid in primary sclerosing cholan..:

Lindström, L. ; Boberg, K. M. ; Wikman, O....
Alimentary Pharmacology & Therapeutics. 35 (2012) 4 - p. 451-457 , 2012

Link: https://doi.org/10.1111/..

4

829 HEPATIC AND EXTRAHEPATIC MALIGNANCIES INAUTOIMMUNE HEPA..:

Werner, M. ; Almer, S. ; Prytz, H...
Journal of Hepatology. 50 (2009) - p. S303 , 2009

Link: https://doi.org/10.1016/..

5

883 EPIDEMIOLOGY AND THE INITIAL PRESENTATION OF AUTOIMMUNE..:

Werner, M. ; Prytz, H. ; Ohlsson, B....
Journal of Hepatology. 48 (2008) - p. S331-S332 , 2008

Link: https://doi.org/10.1016/..

6

Oral budesonide for treatment of autoimmune chronic active ..:

DANIELSSON, Å. ; PRYTZ, H.
Alimentary Pharmacology & Therapeutics. 8 (2007) 6 - p. 585-590 , 2007

Link: https://doi.org/10.1111/..

7

Acute liver failure in Sweden: etiology and outcome:

Wei, G. ; Bergquist, A. ; Broomé, U....
Journal of Internal Medicine. 262 (2007) 3 - p. 393-401 , 2007

Link: https://doi.org/10.1111/..

8

551 Five-year treatment with high-dose UDCA in PSC:

Olsson, R.G. ; Boberg, K.M. ; Schaffalitzky de Muckadel, O....
Journal of Hepatology. 40 (2004) - p. 161-162 , 2004

Link: https://doi.org/10.1016/..

9

HLA class II markers and clinical heterogeneity in Swedish ..:

Wassmuth, R. ; Depner, F. ; Danielsson, Å....
Tissue Antigens. 59 (2002) 5 - p. 381-387 , 2002

Link: https://doi.org/10.1034/..

10

Longitudinal bone loss in postmenopausal women with primary..:

Ormarsdóttir, S. ; Ljunggren, Ö. ; Mallmin, H....
Journal of Internal Medicine. 252 (2002) 6 - p. 537-541 , 2002

Link: https://doi.org/10.1046/..

11

Hepatoduodenal lymphadenopathy in PBC, clinical implication:

Prytz, H. ; Lyttkens, K. ; Forsberg, L..
Journal of Hepatology. 9 (1989) - p. S209 , 1989

Link: https://doi.org/10.1016/..

12

Red cell sodium and potassium contents in liver cirrhosis:

Astrup, J. ; Prytz, H. ; Thomsen, Å.C..
Gastroenterology. 78 (1980) 3 - p. 530-534 , 1980

Link: https://doi.org/10.1016/..

13

KUPFFER CELLS AND CIRRHOSIS:

Bjørneboe, M ; Prytz, H
The Lancet. 305 (1975) 7897 - p. 45-46 , 1975

Link: https://doi.org/10.1016/..

14

ANTIBODIES TO INTESTINAL MICROBES IN SERUM OF PATIENTS WITH..:

Bjørneboe, M. ; Prytz, H. ; Ørskov, F.
The Lancet. 299 (1972) 7741 - p. 58-60 , 1972

Link: https://doi.org/10.1016/..

15

RELATION BETWEEN AUSTRALIA ANTIGEN AND AUTOIMMUNE HEPATITIS:

Bjørneboe, M ; Prytz, H
The Lancet. 299 (1972) 7764 - p. 1335-1336 , 1972

Link: https://doi.org/10.1016/..